Released on: February 13, 2008, 7:58 pm

Press Release Author: Shashi Mashwari / Milton Hayward

Industry: Biotech

Press Release Summary: Asia\\\'s influence on the global biotech industry is gathering
movement. Owing to this, governments in each Asian country has invested in
biotechnology, the science of the future.

Press Release Body: Asia\\\'s influence on the global biotech industry is gathering
movement. Asia's foray into biotechnology has generated a huge interest in
prospective market players due to the sheer market size that has been unused.

In a further press release, Mr. John Cannon, Head of Corporate Trading at Milton
Hayward advised the acquisition of three country portfolios on behalf of regional
government bodies has enhanced the ability to offset funding through the private
sector.

Owing to this, government of each Asian country has invested in biotechnology,
considered as science of future and they are basically the ones who are driving the
biotechnology research. In contrast the role played by Private industry is trivial.

This is primarily because biotechnology research requires huge investment in
infrastructure as well as the returns is quite low in the early years.

China's foray into biotechnology was with a focus on plant genomics and transgenic
technology. It was the Asia's only country, which took part in the human genome
project. Similarly, India was among the front-runners in biotech projects and is set
to emerge as a strong player in the biopharmaceutical market.

Recent report on "Asia Pacific Biotechnology Market (2007-2010)" by The Wall Street
Journal also conveyed similar results, as per which, the biotechnology industry in
Asia-Pacific is expected to play a vital role in the global biotechnology market in
future. The Asia-Pacific region generated estimated revenues worth US$ 39.16 Billion
in 2006.

The report also confirmed the Asian governments' efforts in making biotechnology a
top priority and agreed that the region is largely dependent on the government with
very little private participation in most of the countries.

Likewise the report acknowledged the efforts of China and India (among others) in
the field of biotechnology and talked about the China's Beijing Genomics Institute
that conducted a number of genome sequencing projects including its well-publicized
human genome project. The report also agreed that over US$ 10 Billion worth of
biopharmaceuticals were scheduled to go off patent by the end of 2006 and India,
with its unique pharma and biotech skills, can cash in on this opportunity.

Further, the report also addressed some other interesting issues for today's global
business environment such as market trends in the Asia-Pacific Biotechnology
industry, the role played by the Governments and opportunities that can be leveraged
by the industry.

The report provides an extensive research and objective analysis of the
biotechnology market in Asia-Pacific and help clients in analyzing the opportunities
critical to its growth.


Web Site: http://www.miltonhayward.com

Contact Details: Milton Hayward
Yurakucho Ekimae Building
Level 12
Yurakucho 2-7-1
Chiyoda-ku
Tokyo
Japan
Tel: +81-3 4588-4049
Fax: +81-3-4496-4021
services@miltonhayward.com